KXU-96896-96534
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 672 / KS
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Registered in v-safe
-
2021-02-27
Dose 1 — Pfizer-BioNTech
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-02
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Swollen lymph nodes on side of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-05
- 2021-03-06
- 2021-03-13
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-03-22
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-29
- 2021-04-07
- 2021-04-21
- 2021-04-28
- 2021-05-03
-
2021-06-23
Survey response — 3 months, dose 2MedDRA: Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hives - lower extremitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-23
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-30
-
2021-09-22
Survey response — 6 months, dose 2MedDRA: Gastrointestinal disorder, Hypersensitivity — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: GI issues Increase in allergic reactionsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-22
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-23
-
2022-03-22
Survey response — 12 months, dose 2MedDRA: Immunodeficiency common variable, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Common variable immunodeficiency disorder · Healthcare visit (other): Home health visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-22
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph nodes on side of injection
Release 9 — 3 months, dose 2
Symptoms: Hives - lower extremities
Release 9 — 6 months, dose 2
Symptoms: GI issues Increase in allergic reactions
Release 11 — 12 months, dose 2
Symptoms: Common variable immunodeficiency disorder
Healthcare visit (other): Home health visits
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Immunodeficiency common variable | · | · | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release